Some things old, new and borrowed: Delivery of dabrafenib and vemurafenib to melanoma cells via self-assembled nanomicelles based on an amphiphilic dendrimer.
Amphiphilic dendrimer
BRAF inhibitors
Drug delivery
Melanoma
Self-assembled nanomicelles
Journal
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
ISSN: 1879-0720
Titre abrégé: Eur J Pharm Sci
Pays: Netherlands
ID NLM: 9317982
Informations de publication
Date de publication:
01 Jan 2023
01 Jan 2023
Historique:
received:
08
07
2022
revised:
19
10
2022
accepted:
19
10
2022
pubmed:
24
10
2022
medline:
15
12
2022
entrez:
23
10
2022
Statut:
ppublish
Résumé
Two clinically approved anticancer drugs targeting BRAF in melanoma patients - dabrafenib (DAB) and vemurafenib (VEM) - have been successfully encapsulated into nanomicelles formed upon self-assembly of an amphiphilic dendrimer AD based on two C
Identifiants
pubmed: 36273785
pii: S0928-0987(22)00196-8
doi: 10.1016/j.ejps.2022.106311
pii:
doi:
Substances chimiques
Vemurafenib
207SMY3FQT
Micelles
0
dabrafenib
QGP4HA4G1B
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106311Informations de copyright
Copyright © 2022. Published by Elsevier B.V.